• Exchange: Oslo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Bionor Pharma ASA

+ Add to Watchlist

BIONOR:NO

2.690 NOK 0.080 2.89%

As of 10:25:01 ET on 09/17/2014.

Snapshot for Bionor Pharma ASA (BIONOR)

Open: 2.850 Day's Range: 2.600 - 2.870 Volume: 4,261,157
Previous Close: 2.770 52wk Range: 1.910 - 4.480 1-Yr Rtn: -9.43%

Stock Chart for BIONOR

No chart data available.
  • BIONOR:NO 2.690
  • 1D
  • 1M
  • 1Y
2.770
Interactive BIONOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIONOR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OBX -
Earnings Per Share (NOK) (ttm) -0.3833
Est. EPS (NOK) (12/2014) -0.2800
Est. PEG Ratio -
Market Cap (M NOK) 668.00
Shares Outstanding (M) 248.33
30 Day Average Volume 1,115,966
Price/Book (mrq) 4.3434
Price/Sale (ttm) 155.5171
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) 2.6785
Dividend Ex-Date 12/12/2003
5 Year Dividend Growth -
Next Earnings Announcement 11/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIONOR

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for BIONOR

Bionor Pharma ASA is a biotechnology company. The Company develops therapeutic peptide vaccines that stimulate cell-mediated immunity. Bionor Pharma targets diseases that include chronic infections such as HIV, Hepatitis C (HCV), Human Papilloma Virus (HPV) and Influenza.

Steen KroyerDeputy ChairmanAnker LundemosePresident/CEO
Synne H RoineChief Financial OfficerVidar Wendel-HansenChief Medical Officer
More Company Profile & Key Executives for BIONOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil